TY  - JOUR
N1  - Copyright of this article belongs to Elsevier Science
ID  - open432
UR  - http://crdd.osdd.net/open/432/
IS  - 5
A1  - Mukhopadhyay, A
A1  - Basu, S K
Y1  - 1990/10//
N2  - In the present investigation we have described a method of enhancing the uptake of methotrexate by macrophages. This enhanced uptake was mediated by endocytosis through the "scavenger receptor" system which recognized maleylated bovine serum albumin. Experimental evidence showed that macrophages internalized methotrexate coupled to maleylated bovine serum albumin through a saturable process at 37 degrees C leading to an eightfold higher concentration of cell-associated methotrexate compared to the free drug. Following uptake, the drug conjugate was degraded in the lysosomes leading to intracellular release of a pharmacologically active form of methotrexate. When administered to macrophages infected with Leishmania mexicana amazonensis, the drug conjugate could eliminate the intracellular amastigotes more efficiently than the free drug. The leishmanicidal effect of the drug conjugate was inhibited in the presence of excess maleylated bovine serum albumin and lysosomal inhibitors such as chloroquine and monensin. Addition of folinic acid to the medium also prevented the elimination of the amastigotes by the drug conjugate. These results suggested that the scavenger receptor-mediated endocytosis of the drug conjugate led to enhanced transport and intracellular release of a pharmacologically active form of methotrexate resulting in more efficient killing of the amastigotes compared to the free drug. This modality of delivering drugs selectively to macrophages might have utility in the chemotherapy of macrophage-associated disorders in general.
PB  - Elsevier Science
JF  - Biotechnology and applied biochemistry
VL  - 12
SN  - 0885-4513
TI  - Enhanced intracellular delivery of methotrexate by a receptor-mediated process.
SP  - 529
AV  - none
EP  - 36
ER  -